Skip to content

Safety Study of Colonoscopy Under Sedation

Tolerance and Acceptability of Colonoscopy Under Sedation by an Equimolar Mixture of Oxygen and Nitrous Oxide. Comparison With General Anesthesia in a Randomized, Multicentric Study.

Status
Terminated
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00930358
Acronym
KALINAG
Enrollment
220
Registered
2009-06-30
Start date
2009-02-28
Completion date
2011-01-31
Last updated
2011-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colonoscopy Procedure

Keywords

Sedation, Colonoscopy, General anesthesia

Brief summary

The aim of this study was to compare the analgesia provided by nitrous oxide/oxygen sedation or general anesthesia for colonoscopy

Detailed description

The purpose of this protocol is to compare two methods of analgesia/sedation for colonoscopy. Sedation and analgesia induced by a 50% nitrous oxide/oxygen mixture could sufficient to allow the practice of colonoscopy instead of general anesthesia which is accompanied with certain risks and post procedure drowsiness.

Interventions

DRUGMEOPA

anaesthetic gaz inhalation

DRUGgeneral anaesthesia

Anaesthetic intravenous route

Sponsors

Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

1. Patient referred for colonoscopy with general anesthesia 2. Age above 18 et below 75 year 3. Patient who gave an informed consent

Exclusion criteria

1. Age below 18 ou above 75 2. Need for gastroscopy in the same procedure than colonoscopy 3. History of surgery wih resection more extended than half of the colon 4. Dementia with autonomy loss or psychiatric disorder non controlled by therapeutic 5. Severe congestive heart failure or evolutive heart ischemia 6. Recent cerebral stroke 7. Hemodynamic instability 8. Respiratory failure, severe chronic obstructive pulmonary (including asthma) or progressive pneumothorax 9. Hepatic failure (Child-Pugh score\> 9) 10. Terminal renal failure 11 Hematopoietic disorders 12\. Pathology with expected survival shorter than the duration of the study and cancer excepted basal cell carcinoma of the skin 13. Alcohol consumption higher than 100 gr per day 14. Pregnancy or breastfeeding at the inclusion period

Design outcomes

Primary

MeasureTime frameDescription
Percentage of patients who have well tolerated the colonoscopy as assessed by visual analogic scale (>75/100)Immediately after the colonoscopy
The mean grade of patient anxiety before endoscopyAfter the colonoscopyThe mean grade of patient anxiety before endoscopy

Secondary

MeasureTime frame
The mean patient satisfaction on a visual analogic scale.after the colonoscopy
The percentage of patients who agree to repeat the procedure in similar circumstances.after the colonoscopy
The grade of difficulty of the colonoscopy evaluated by the endoscopistAfter the colonoscopy
The mean duration of the endoscopyAfter the colonoscopy
The percentage of caecum intubationAfter the colonoscopy
The mean tolerability of the colonoscopy between the group with sedation by nitrous oxide/oxygen mixture and the group with anesthesiaafter the colonoscopy
The opinion of the endoscopist on the tolerance of the colonoscopyAfter the colonoscopy
The time to hospital dischargeAfter the issue of the colonoscopy
The Aldrete's score at the hospital dischargeAfter the colonoscopy
The number of patient who have refused the inclusionAfter the issue of the colonoscopy
The percentage of ileal intubationAfter the colonoscopy
The mean pain intensity during the procedure on a visual analogic scaleafter the colonoscopy

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026